glp 1 coverage Costly GLP-1 Drugs are Rarely Covered for Weight Loss by Marketplace Plans Medical Coding GLP-1 Medications |
Description
But when I was taking Mounjaro, my appetite was absolutely different
Gastrointestinal symptoms nausea, diarrhea, constipation are most common, especially early
Novo Nordisk is the market leader: Ozempic (weekly injection for type 2 diabetes) Wegovy (higher-dose weekly injection for obesity) Rybelsus ( Oral tablets for diabetes Oral tablets for weight management is in phase 3 trials) Eli Lilly is the other major player: Mounjaro (weekly injection for type 2 diabetes) Zepbound (higherdose weekly injection for obesity) This duopoly meant that both stocks had an incredible run-up from 2020 to 2024
Take the First Step If youre ready to discover if GLP-1 medications are right for you, we encourage you to take our free assessment quiz here
GLP-1 drugs in Europe While the GLP-1 weight-loss trend began in the US, it has quickly spread to Europe
